Healthtech startup finance is more complex because these companies’ financial needs depend on factors like business model, sales cycles, commercialization timelines, regulatory milestones, payment structures, and capital requirements. Unlike a traditional startup, healthtech businesses require financial strategies and models built around how they operate.
Let’s be honest. With the industry estimated to hit $3,140.9 billion by 2033, now’s a great time to be running a health-tech startup. And if you already are, there’s no shortage of things competing for your attention. Product development, customers, and compliance all seem to be beating down the door.
But you also have to consider health-tech startup finance.
At first, it can feel pretty simple. You have a budget, a forecast, some basic financial reports, and maybe a spreadsheet that has somehow become the company’s holy grail.
Then things start moving. A new customer takes longer to close. A pilot turns into a contract, but not quite as quickly as expected. Hiring gets pulled forward. Or a major milestone shifts by a quarter.
Suddenly, that once-glorious health-tech financial model is looking a little less amazing. This isn’t necessarily because anything’s wrong. It’s probably because the model wasn’t built to reflect how your business works.
As we discussed in our last article, “Why Finance Strategy Breaks Down as Businesses Become More Complex,” growing companies eventually need financial strategies that evolve with the business. Health-tech is no exception.
A health-tech startup isn’t just a normal startup with the word “health” sprinkled on top. These companies have different models, revenue paths, commercialization timelines, capital needs, and, depending on the business, regulatory, clinical, payer, or reimbursement considerations.
So the question you should be asking isn’t, “What should a health-tech startup’s financial model look like?”
It’s: “What should your financial model look like based on how your business operates?”
That’s where things get interesting.
First, Forget the Idea of a “Typical” Health-Tech Startup
One of the easiest mistakes in health-tech finance is assuming that because two companies operate in the same industry, they should be measured and modeled the same way.
They shouldn’t.
Take a B2B healthcare SaaS company. Its financial model might revolve around recurring revenue, customer acquisition costs, retention, expansion, gross margins, and sales cycle length.
Now compare that with a medical device startup. The company may need to invest significantly in product development and commercialization before revenue reaches meaningful scale. The timing of major milestones could have an enormous impact on capital requirements.
Same broad industry. Very different financial realities.
That’s why healthcare startup finance has to start with a deceptively simple question: How does this particular business make money?
Not how does a startup make money. Not how does health-tech make money.
How does this business make money?
Once you understand that, you can start building the financial model around the path from investment to milestone to revenue to cash. That’s a much better place to start.
Why Traditional Startup Forecasts Miss the Mark
Traditional startup forecasting tends to rely on some familiar assumptions:
“We’ll add 20 customers.”
“Revenue will grow 30%.”
“We’ll hire five people.”
“Operating expenses will increase by X.”
Simple enough, right? Well… sometimes.
Health-tech businesses have more moving parts between an assumption and the outcome.
Maybe a new customer starts with a pilot. Maybe the pilot takes three months. Maybe implementation takes another two. Or maybe your company needs to hit a clinical, regulatory, or commercialization milestone before the next big revenue opportunity becomes realistic.
Suddenly, “20 new customers this year” isn’t really a financial assumption. It’s the end of a much longer story which needs to make its way into the model.
Depending on the business, your startup financial forecast may need to account for regulatory milestones, clinical validation, implementation timelines, payer or reimbursement dynamics, and more.
This is where we see a lot of forecasting problems pop up. If assumptions don’t align with what has to happen inside the company, your model isn’t giving leadership useful information.
Recently, we helped one healthcare company dig deeper into their sales forecast to better understand what was driving results.
When you’re selling through prescribers, distributors, sales reps, or provider networks, forecasting isn’t always as simple as estimating how many customers you’ll bring in. Prescriber behavior, rep productivity, distributor commissions, onboarding timelines, raw-material availability, and reimbursement delays can all affect when sales happen.
Here’s where things get tricky: a sales number that’s falling short doesn’t mean customers aren’t interested. Adventum helped the client take a closer look at those elements so they could start asking more useful questions and get a clearer picture of what was happening beneath the numbers.
Cash and Revenue Don’t Always Move Together
Here’s another thing that catches founders off guard. Revenue growth doesn’t automatically equal cash-flow comfort.
You can have a great sales quarter and still have a very real cash problem.
Why?
Because signing a contract, recognizing revenue, receiving payment, and spending money to deliver the work don’t necessarily happen at the same time. Implementation costs, customer payment terms, upfront commercialization expenses, and other factors can create gaps.
And in businesses where reimbursement or payer dynamics matter, payment timing adds another layer of complexity to healthcare financial management.
Smart healthcare financial planning evaluates when cash arrives and what you have to spend before it does. In other words, your startup cash burn rate.That means watching customer concentration, payment timing, upcoming investments, hiring plans, and the capital needed to reach the next major milestone.
Revenue is super important. But when you’re running a startup, cash is the thing that pays the bills while you’re waiting for the revenue to show up. A forecast that doesn’t connect those two realities can give you a surprisingly rosy picture.
Your KPIs Should Tell Your Story
If your KPI dashboard has 37 metrics, congratulations. You have successfully created another thing nobody wants to look at.
You shouldn’t track every number imaginable; you should identify the financial KPIs that tell you whether your specific business model is working.
For one health-tech company, that might mean focusing heavily on:
- Gross margin
- CAC and LTV
- Recurring revenue
- Retention and churn
- Pipeline conversion
For another, the more important metrics could include:
- Contracted versus recognized revenue
- Implementation timelines
- Customer concentration
- Runway
- Commercialization milestones
- Operational milestones
- Regulatory or clinical milestones
- Reimbursement metrics, where applicable
The right KPI dashboard depends on the business. And that’s a good thing. Your financial reporting shouldn’t be a collection of metrics that someone told you a startup is supposed to track. It must help leadership understand what’s really going on.
Investor Expectations Add Another Layer
To build trust, health-tech investors need to understand more than what happened financially last quarter. Depending on the business, the investment story can connect financial performance with operational and strategic milestones, such as:
- What regulatory or clinical milestones have been reached?
- How is commercialization progressing?
- How much capital will the company need to reach its next milestone?
- How much runway remains?
- What operating risks could change the forecast?
- What growth milestones are realistic?
Your operational story and financial story need to work together to improve investor relations.
If the company expects a major increase in revenue, investors should know what’s driving that increase. If reaching the next milestone requires additional capital, that must be visible in the financial plan.
Strong healthcare financial management makes those links easier to see. This matters internally, too. A financial model isn’t just something you pull out before a board meeting or fundraising process. It should help leadership understand the business throughout the year.
The Spreadsheet Usually Isn’t the Problem
When a company reaches a certain stage, founders sometimes assume they need a more sophisticated spreadsheet. Maybe.
But often, the bigger issue is that the finance process hasn’t evolved with the business.
You may notice it in small ways at first. The forecast misses again, finance and sales are using different assumptions, or leadership asks, “What if we delay this launch by three months?” and the answer requires a heroic amount of spreadsheet gymnastics.
Then fundraising starts, and suddenly everyone wants more detail. These are signs that the company may be moving beyond early-stage finance. Other red flags to watch out for include:
- Future cash needs aren’t clear
- Forecast assumptions aren’t connected to operational realities
- Scenario planning has become increasingly important
- Different teams are working from different assumptions
- Reporting has become highly manual
- The company is entering a new commercialization or growth stage
- Financial reporting tells you what happened but doesn’t help you decide what to do next
That last point is particularly important. There’s a difference between financial reporting and financial strategy. Reporting tells you where you’ve been, while strategy helps you think about where you’re heading.
As a health-tech company becomes more complex, that forward-looking perspective becomes increasingly valuable.
Adventum helps our health-tech clients look beyond monthly reports and think through real-world possibilities, like enrollment taking longer than planned, payments arriving late, or the company needing to bring on another employee.
The financial visibility we provide lets leadership make decisions with a clearer sense of what lies ahead.
Build Health-Tech Startup Finance Around How the Business Works
This is really the heart of the issue. Finance shouldn’t exist in a separate corner of the business, waiting for everyone else to make decisions so it can document what happened.
The best finance function is part of the decision-making process:
- Can we afford to accelerate this investment?
- What happens if the sales cycle gets longer?
- Should we preserve cash for the next milestone?
- What happens to runway under a slower-growth scenario?
- How much capital will we need, and when?
These aren’t accounting questions. They’re business questions with financial consequences. A healthcare startup CFO can make a huge difference by helping you better understand the assumptions behind the plan, identify the variables that matter most, and know what different scenarios could mean for the business.
Health-Tech Doesn’t Need More Finance. It Needs Better-Fit Finance.
There’s no universal financial playbook for health-tech startups. And that’s probably a good thing. Your business model is unique. Your financial strategy should be, too.
As your company grows, a health-tech financial strategy and a fractional CFO for health-tech startups help build a financial model and processes that reflect how your business operates and give leadership the information they need to make smarter decisions.
This is just the beginning of the conversation. As our Health-Tech Finance series continues, we’ll dig deeper into the financial challenges that can emerge as health-tech companies evolve and grow. Stay tuned.